Novartis AG (NYSE:NVS) Enters Agreement To Produce CureVac’s CVnCoVCOVID-19 Vaccine
Novartis AG (NYSE:NVS) has signed an agreement with CureVac NV to produce its CVnCoV COVID -19 vaccine candidate. The deal
Read more
Novartis AG (NYSE:NVS)
Novartis AG (NYSE:NVS) Enters Agreement to Acquire Cadent Therapeutics for $770 Million
Novartis AG (NYSE:NVS) has signed a definitive agreement to acquire all outstanding capital stock of US-based neurosciences firm Cadent Therapeutics
Read more